My 'theories' come from facts, not ideas.
MannKind are entirely dependent on partnering to achieve their goals -
bringing innovative therapies to patients and their caregivers, and partnering is at the core of our business strategy. And their focus' of - establishing partnerships to build therapeutic programs of significant clinical and commercial value and the discovery, development and commercialization of therapeutic products for patients.
They are a not young company, but their focus became Afrezza....and well the rest is playing out before all of us.